Paul Ruff to Neuroendocrine Tumors
This is a "connection" page, showing publications Paul Ruff has written about Neuroendocrine Tumors.
Connection Strength
0,155
-
Efficacy and Safety of Sunitinib in Patients with Well-Differentiated Pancreatic Neuroendocrine Tumours. Neuroendocrinology. 2018; 107(3):237-245.
Score: 0,155
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.